Citius Pharmaceuticals CTXR
NASDAQ CTXR
$0.59 +0.01 (+1.86%)
As of: Sep 10, 2026 · 11:40 AM EDT

Citius Pharmaceuticals (CTXR) Debt Ratio (2011 - 2026)

Citius Pharmaceuticals' (CTXR) quarterly Debt Ratio came in at 0.05 in Q2 2026, up 475.32% on a YoY basis from 0.01 in Q2 2025, and up 532.62% quarter-over-quarter from 0.01 in Q4 2025.

Analysis

Citius Pharmaceuticals (CTXR) Debt Ratio (2011 - 2026) Analysis & Trends

Citius Pharmaceuticals (CTXR) has reported Debt Ratio for 13 consecutive years, with 0.05 the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Debt Ratio rose 475.32% year-over-year to 0.05; the trailing twelve-month figure through Jun 2026 stood at 0.05 (up 475.32% YoY), and the FY2025 full-year result was 0.01, changed N/A from the prior year.
  • Debt Ratio rose to 0.05 in Q2 2026 per CTXR's latest filing, from 0.01 in the prior quarter.
  • Across five years, Debt Ratio topped out at 0.05 in Q2 2026 and bottomed at 0.01 in Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt Ratio (Qtr)
1 Johnson & Johnson 641.22 Bn 620.47 Bn 17.26 Bn 0.30
2 AbbVie 446.28 Bn 439.71 Bn 12.70 Bn 0.52
3 Merck 357.56 Bn 350.42 Bn 12.21 Bn 0.42
4 Novartis Ag 268.11 Bn 260.42 Bn 11.24 Bn 0.08
5 Pfizer 156.86 Bn 145.17 Bn 10.94 Bn 0.31
6 Sanofi 52.10 Bn 44.72 Bn 10.79 Bn 0.17
7 Revolution Medicines 43.01 Bn 43.01 Bn - -
8 Incyte 24.82 Bn 20.28 Bn 1.57 Bn 0.00
9 United Therapeutics 21.39 Bn 18.73 Bn 683.80 Mn -
10 Citius Pharmaceuticals 15.27 Mn 15.27 Mn 1.00 Mn 0.05
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 0.05
Dec 31, 2025 0.01
Sep 30, 2025 0.01
Jun 30, 2025 0.01
Jun 30, 2021 0.00
Mar 31, 2021 0.00
Dec 31, 2020 0.01
Sep 30, 2020 0.01
Jun 30, 2020 0.01
Mar 31, 2020 0.01
Dec 31, 2019 0.01
Sep 30, 2019 0.00
Jun 30, 2019 0.01
Mar 31, 2019 0.01
Dec 31, 2018 0.01
Sep 30, 2018 0.01
Jun 30, 2018 0.01
Mar 31, 2018 0.01
Dec 31, 2017 0.01
Sep 30, 2017 0.01